ERBB2 and breast carcinoma: 32 Moreover it is found that s-HER-2 elevation in early breast cancer correlates with the principal criteria of tumor aggressiveness and vascular invasion.33 It can act as independent prognostic factor enabling to identify patients likely to benefit from more aggressive treatments at the early stages of tumor metastasis.